4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-026555
VP Finance & Accounting bought 2,300 shares at $9.00 ($20,700)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thomson Peter G. VP Finance & Accounting | 2021-06-28 | Purchase | +2,300 | $9.00 | $20,700 | 2,300 | I: show line 1 in the form |
| Open-market purchases · 2,300 sh · avg $9.00 · $20,700 | |||||||
Loading xslF345X03/doc4.xml…